Measuring autophagy accurately often comes down to interpreting two widely used markers: LC3 and p62 (also called SQSTM1). While these proteins are helpful, their levels can be misleading unless you understand whether you’re seeing autophagosome formation, cargo delivery, or degradation inside lysosomes. This FAQ hub focuses on the practical interpretation of LC3 and p62 signals, how to validate autophagy flux, and what common experimental factors can change the readout.

What do LC3 and p62 measure in the autophagy pathway?

LC3 is a core autophagy protein that becomes lipidated (commonly reported as LC3-II) and associates with autophagosomal membranes. Higher LC3-II generally indicates more autophagosomes, but it does not automatically mean autophagy is increasing overall because autophagosomes could also be accumulating due to impaired degradation.

p62/SQSTM1 is an adaptor protein that binds ubiquitinated cargo and is itself degraded in autolysosomes. When autophagy is functioning, p62 typically decreases over time as it is cleared. When lysosomal degradation is blocked, p62 can accumulate.

How should LC3-II increase be interpreted?

An increase in LC3-II can reflect either increased autophagosome biogenesis or reduced autophagic clearance. To distinguish these possibilities, researchers usually measure autophagic flux, typically by comparing conditions with and without lysosomal inhibitors (such as bafilomycin A1 or chloroquine, depending on the experimental system). If LC3-II rises further when degradation is blocked, that supports increased flux rather than a complete blockage.

What does a decrease in p62 usually indicate?

A decrease in p62 often indicates that cargo is being delivered to lysosomes and degraded efficiently. However, p62 can also be regulated at the transcriptional level by stress pathways (for example, NRF2-related responses), so p62 reduction is most convincing when paired with flux information or additional controls.

What does p62 accumulation mean in autophagy marker interpretation?

p62 accumulation commonly suggests impaired autophagic degradation. This can occur when lysosomal function is reduced, when autophagosomes fail to fuse with lysosomes, or when cargo delivery is disrupted. It can also increase due to changes in gene expression or proteasome impairment, so it’s important to interpret p62 in context of the full experimental design.

Why is autophagy flux more informative than single time-point LC3 or p62 levels?

Autophagy is dynamic. A snapshot of LC3-II or p62 at one time point can be ambiguous because it cannot tell whether the cell is making more autophagosomes, stopping their clearance, or both. Flux assays help by showing whether the pathway is capable of increasing degradation when the lysosome is inhibited or supported. In practice, flux is often evaluated by comparing LC3-II and p62 changes under baseline conditions versus lysosomal inhibition.

How do lysosomal inhibitors help interpret LC3 and p62?

Lysosomal inhibitors prevent autophagosome contents from being degraded. If autophagic flux is active, blocking lysosomal degradation typically causes LC3-II to accumulate more strongly and p62 to build up because degradation can’t proceed. If LC3-II does not accumulate further with lysosomal inhibition, it may indicate a bottleneck earlier in the pathway (for example, reduced autophagosome formation) or a system already at a maximal accumulation state.

Interpretation depends on inhibitor choice, timing, and cell type, so it’s important to use appropriate controls and time-course sampling.

What are common reasons LC3-II results can be confusing?

Several factors can complicate LC3 interpretation:

• Autophagy induction vs clearance mismatch: LC3-II may rise due to either increased formation or decreased degradation.
• Timing: LC3-II changes rapidly; sampling too early or too late can mask flux differences.
• Protein loading and normalization: LC3-II is sensitive to sample handling and loading controls; normalization errors can mimic biological effects.
• Gel resolution and antibody specificity: LC3-II runs at a distinct molecular weight, but poor separation or cross-reactivity can distort bands.
• Cell stress unrelated to autophagy: Treatments that broadly stress cells can influence lipidation and protein turnover independent of autophagy flux.

How should p62 be normalized and validated for interpretation?

p62 is often assessed by immunoblotting or immunostaining. For interpretation, normalization is critical: use a stable loading control for immunoblots and consider cell viability and total protein content. Because p62 can be transcriptionally regulated, it’s helpful to check whether p62 changes align with other autophagy-related readouts (for example, LC3 flux, lysosomal markers, or cargo degradation assays). If p62 increases while LC3 flux is unchanged, that may point to non-autophagic regulation.

Does LC3 localization by immunofluorescence equal autophagy flux?

Not necessarily. Increased puncta of LC3 can indicate autophagosome formation, but puncta can also increase when degradation is blocked. Immunofluorescence is therefore more informative when combined with flux logic—such as comparing with and without lysosomal inhibitors—so you can infer whether puncta represent productive turnover or accumulation.

Also consider that puncta scoring depends on imaging settings, thresholding, and cell morphology. Standardizing analysis across conditions reduces interpretation errors.

How do you interpret LC3 and p62 when mTOR signaling is involved?

mTOR generally suppresses autophagy initiation. When mTOR activity decreases, autophagy initiation often increases, which can lead to increased LC3-II and subsequent p62 clearance if lysosomal degradation is intact. If p62 does not decrease despite LC3-II changes, it may suggest that initiation is occurring but clearance is impaired.

Because mTOR also influences protein synthesis and cellular stress responses, it’s valuable to include flux measurements rather than relying on LC3-II alone.

How should NAD+ and metabolic shifts affect LC3/p62 interpretation?

NAD+ availability can influence cellular metabolism and stress signaling, which may indirectly modulate autophagy. In systems where metabolic changes alter lysosomal function, LC3-II may accumulate even if initiation is not the dominant effect. Conversely, improved metabolic balance might enhance autophagic clearance, reflected by reduced p62.

Because NAD+-related pathways can affect transcription, redox status, and mitochondrial turnover, interpret LC3 and p62 alongside functional assays of degradation and cell health metrics.

What does it mean if LC3-II increases but p62 also increases?

This pattern often suggests an accumulation phenotype: autophagosomes are forming (or at least LC3 lipidation is increasing), but degradation is blocked or insufficient. Common causes include lysosomal dysfunction, impaired autophagosome-lysosome fusion, or strong cargo delivery with reduced clearance.

To clarify the mechanism, many studies add flux conditions. If lysosomal inhibition further increases LC3-II, it supports ongoing flux with a clearance bottleneck. If there’s little additional change with inhibition, formation may be the limiting factor or the system may already be maximally impaired.

What if both LC3-II and p62 decrease together?

When LC3-II decreases and p62 decreases, it often suggests reduced autophagosome accumulation with effective clearance, but the interpretation depends on whether flux is increasing or decreasing. In some contexts, autophagy activation is transient; at certain sampling times, LC3-II may not remain elevated even while p62 is being cleared.

Using a time course and flux comparison with lysosomal inhibition helps determine whether the pathway is actively turning over cargo or whether both markers simply reflect reduced baseline autophagy.

How can you confirm that p62 changes reflect autophagy rather than proteasome effects?

p62 is degraded by both autophagy and proteasome-related pathways, depending on the cellular context and cargo type. If a treatment also affects proteasome activity, p62 may rise due to reduced proteasomal degradation rather than reduced autophagy. A practical approach is to include autophagy-specific flux logic (lysosomal inhibition) and, when feasible, assess autophagy cargo degradation markers beyond p62.

Interpreting p62 confidently improves when you can show that lysosomal blockade shifts p62 in the expected direction relative to LC3 flux.

Are there validated commercial tools for LC3 and p62 detection, and what should you check?

Yes—researchers commonly use validated antibodies for LC3 and p62 for immunoblotting and immunofluorescence. Many labs also use autophagy-focused reagents and assay kits that include controls for flux experiments. When selecting reagents, check:

• Antibody specificity: Confirm that LC3-II bands are resolved correctly and that p62 recognizes the expected molecular weight.
• Validation data: Prefer vendors that provide validation in relevant species and applications.
• Application fit: Use antibodies that are validated for immunoblotting or microscopy as needed.
• Controls: Include positive and negative controls for autophagy modulation and verify expected responses in your cell type.

Even with high-quality tools, interpretation still depends on flux design and proper normalization.

What are best-practice controls for LC3 p62 interpretation in experiments?

Strong experimental design reduces ambiguity. Common best practices include:

• Time-course sampling: Collect multiple time points to capture transient responses.
• Flux assessment: Compare with and without lysosomal inhibitors to infer productive turnover.
• Consistent normalization: Use reliable loading controls and ensure equal protein amounts.
• Orthogonal readouts: Pair LC3/p62 with lysosomal markers, cargo degradation indicators, or electron microscopy when feasible.
• Cell viability checks: Treatments that cause strong cell death can alter protein turnover independent of autophagy.

These controls help translate marker changes into pathway-level conclusions.

How should you report LC3 and p62 results for clarity?

Clear reporting improves reproducibility. Include whether you measured:

• LC3-II with a description of inhibitor conditions (if used) and time points
• p62 levels with normalization details
• Whether conclusions are based on flux (degradation capacity) or on marker abundance at a single time point
• Any additional markers used to support the interpretation

When you frame results as “autophagosome accumulation” versus “autophagic degradation,” you reduce misunderstandings in downstream interpretation.

Summary: How to interpret autophagy markers LC3 and p62 reliably

LC3 and p62 are powerful autophagy markers, but their meaning depends on whether you’re observing formation, accumulation, or degradation. LC3-II changes can reflect either increased autophagosome biogenesis or impaired clearance, while p62 often decreases with effective lysosomal degradation and accumulates when degradation is blocked. The most reliable interpretation comes from autophagy flux logic—typically by comparing conditions with and without lysosomal inhibitors—plus careful normalization, time-course sampling, and orthogonal validation.

11.04.2026. 09:38